日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway

FAAH 抑制剂/URB597 与铁死亡诱导剂联合治疗可通过 PI3K-AKT 信号通路显著降低肾细胞癌细胞的生长和转移

期刊:Cell Death & Disease
影响因子:8.1
doi:10.1038/s41419-023-05779-z
Junfeng Hao #, Qiguang Chen #, Yongmin Feng #, Qiyu Jiang, Huiwei Sun, Botian Deng, Xin Huang, Jibin Guan, Qiuping Chen, Xincheng Liu, Yanjin Wang, Peng Cao, Fan Feng, Xiaoyu Li
信号转导
细胞生物学
肿瘤
肾癌
肿瘤细胞
PI3K/Akt
发表日期：2023
文献求助 收藏

A Novel Small-Molecule Inhibitor of SREBP-1 Based on Natural Product Monomers Upregulates the Sensitivity of Lung Squamous Cell Carcinoma Cells to Antitumor Drugs

基于天然产物单体的新型SREBP-1小分子抑制剂上调肺鳞状细胞癌细胞对抗肿瘤药物的敏感性

期刊:Frontiers in Pharmacology
影响因子:4.4
doi:10.3389/fphar.2022.895744
De-Bin Ma, Xing-Yu Liu, Hui Jia, Yingshi Zhang, Qiyu Jiang, Huiwei Sun, Xiaojuan Li, Fang Sun, Yantao Chai, Fan Feng, Lei Liu
肿瘤
肺癌
肿瘤细胞
发表日期：2022
文献求助 收藏

Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs

TANK 结合激酶 1 的敲低增强了肝细胞癌细胞对分子靶向药物的敏感性

期刊:Frontiers in Pharmacology
影响因子:4.4
doi:10.3389/fphar.2022.924523
Fengxia Du, Huiwei Sun, Fang Sun, Shiwei Yang, Haidong Tan, Xiaojuan Li, Yantao Chai, Qiyu Jiang, Dongdong Han
免疫
细胞生物学
肝癌
肿瘤细胞
发表日期：2022
文献求助 收藏

A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma

单核苷酸混合物增强分子靶向药物对肝细胞癌的抗肿瘤活性

期刊:Frontiers in Pharmacology
影响因子:4.4
doi:10.3389/fphar.2022.951831
Da Mao, Meihong Xu, Qiyu Jiang, Huiwei Sun, Fang Sun, Ruichuang Yang, Yantao Chai, Xiaojuan Li, Boan Li, Yong Li
肿瘤
肝癌
其它细胞
发表日期：2022
文献求助 收藏

Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4

Hsa-miR-4277 通过靶向 cyp3a4 减缓肝癌细胞中索拉非尼的代谢或清除，并增强肝癌细胞对索拉非尼的敏感性

期刊:Frontiers in Oncology
影响因子:3.5
doi:10.3389/fonc.2021.735447
Xi He, Huiwei Sun, Qiyu Jiang, Yantao Chai, Xiaojuan Li, Zhijie Wang, Bing Zhu, Shaoli You, Boan Li, Junfeng Hao, Shaojie Xin
代谢
肿瘤
肝癌
肿瘤细胞
发表日期：2021
文献求助 收藏

Quantitative examination of the inhibitory activation of molecular targeting agents in hepatocellular carcinoma patient-derived cell invasion via a novel in vivo tumor model

通过新型体内肿瘤模型定量检查分子靶向药物对肝细胞癌患者来源细胞侵袭的抑制激活

期刊:Animal Models and Experimental Medicine
影响因子:3.8
doi:10.1002/ame2.12085
Huiwei Sun, Fan Feng, Hui Xie, Xiaojuan Li, Qiyu Jiang, Yantao Chai, Zhijie Wang, Ruichuang Yang, Ruisheng Li, Jun Hou
肿瘤
肝癌
肿瘤细胞
发表日期：2019
文献求助 收藏

Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells

新型 ADAM-17 抑制剂 ZLDI-8 增强索拉非尼对肝细胞癌细胞的体外和体内化疗作用

期刊:Cell Death & Disease
影响因子:8.1
doi:10.1038/s41419-018-0804-6
Yingshi Zhang, Dandan Li, Qiyu Jiang, Shuang Cao, Huiwei Sun, Yantao Chai, Xiaojuan Li, Tianshu Ren, Ruichuang Yang, Fan Feng, Bo-An Li, Qingchun Zhao
肿瘤
肝癌
肿瘤细胞
FCM
IF
IHC-P
WB
NOTC1
发表日期：2018
文献求助 收藏

FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth

FHL1 与雌激素受体相互作用并调节乳腺癌细胞生长

期刊:Journal of Cellular and Molecular Medicine
影响因子:4.3
doi:10.1111/j.1582-4934.2009.00938.x
Lihua Ding, Chang Niu, Yiqiong Zheng, Zhihong Xiong, Yufei Liu, Jing Lin, Huiwei Sun, Ke Huang, Wen Yang, Xiru Li, Qinong Ye
肿瘤
乳腺癌
肿瘤细胞
发表日期：2011
文献求助 收藏